Global Newborn Screening Market - Industry Analysis And Market Forecast (2015-2020)
|発行||Mordor Intelligence LLP||商品コード||319330|
|世界の新生児スクリーニング市場：業界分析と市場予測 Global Newborn Screening Market - Industry Analysis And Market Forecast (2015-2020)|
|出版日: 2016年01月01日||ページ情報: 英文||
The Global Newborn Screening market is expected to reach USD XX million by 2020 growing at a CAGR of XX%. The newborn Screening is performed to screen infants after birth for detection of any health conditions or diseases that can be fatal but are not depicted during birth. The newborn screening tests are basically evaluation of metabolites and blood samples. The newborn screening tests varies according to different country jurisdictions. In many areas newborn screening test includes screening for hearing loss, congenital heart disease etc. The major diseases screened are sickle cell disease, cystic fibrosis, newborn hearing loss, congenital hypothyroidism, phenyl ketone urea, congenital heart disease, and others.
The presence of federal bodies for organizing awareness programmes, increasing awareness in developed countries, technological advancements in healthcare, and increasing array of newborn diseases are propelling the growth of this market. However, unawareness in developing countries, lack of trained professionals and socio-economic barriers in developing countries are posing restraint to the growth of this market.
The global newborn screening market have been segmented based on technology, product, and test type. The segmentation based on technology have been subdivided into tandem mass spectrometry, DNA based assay, enzyme and immunoassays, electrophoresis, hearing screening technology, and pulse Oximetry technology. The segmentation based on product sub-divided into newborn disorder screening instruments, hearing screening devices and accessories, Pulse Oximetry, and Reagents and assay kits. The segmentation based on Test Type have been sub-divided into critical congenital heart disease test, hearing screening test, and dry blood spot test.
The global Newborn screening test Market have been segmented based on geography as North America, Europe, Asia-Pacific, Middle East and North Africa, and South America. The segmentation on North America discusses different market trends, and market size of newborn screening tests in USA, Canada and Mexico. The Europe segment have been further subdivided into UK, France, Italy, Germany, Benelux, Scandinavia, Spain and Portugal. The segmentation on Asia-Pacific have been subdivided into China, Japan, India, South Korea, Australia, and New Zealand. The Middle-east & North Africa segment includes GCC, Egypt, and others. The South America region includes Brazil, Argentina, Colombia and others.
The technological advancement in healthcare and more physicians advising newborn screening test and increasing awareness amongst people are some crucial factors that are propelling the growth of this market. Amongst technology being used tandem mass spectrometry is expected to have the fasted growth rate during the forecast period. The Dry blood spot test has the largest market share amongst segmentation by test type. The key players in this market are Agilent Technologies, AB Sciex LLC, Covidien PLC, PerkinElmer Inc., Trivitron Healthcare, Bio-rad Laboratories, Masimo Corporation, Natus Medical, Waters Corporation and GE Healthcare.